AIM Biotech

AIM Biotech AIM Biotech's platform and world-class lab services let drug researchers get more relevant, human-focused data at every stage of development.

Big News! AIM Biotech and MatTek Life Sciences are partnering to supply AIM’s humanized microfluidic models for and ...
01/06/2023

Big News! AIM Biotech and MatTek Life Sciences are partnering to supply AIM’s humanized microfluidic models for and the development of new medicines. For researchers in North America who are already using AIM systems and for those who are interested in starting with one of AIM’s humanized in-vitro models, this means enhanced U.S.-based technical expertise and faster order fulfillment from MatTek’s U.S. inventory:
https://www.mattek.com/store-category/organ-on-a-chip-systems/

Reach out to MatTek or AIM Biotech to learn more about how this changes the game for enabling humanized / non-animal drug discovery research, and check out the press release here!
https://aimbiotech.reportablenews.com/pr/mattek-and-aim-partner-on-advanced-3d-tissue-culture-systems

05/04/2023

AIM Biotech is thrilled to continue our work with Nikon Instruments. As part of this ongoing collaboration, Nikon has leveraged their world-class biological imaging expertise in combination with AIM Biotech’s advanced Blood Brain Barrier (BBB) model to create an optimized process for assessing both the neurotherapeutic transport efficiency of investigative drugs, and the pathological neurovascular functions of various disease states. Check out the latest application note from Nikon and AIM scientists using the Nikon AX/AX R Confocal Microscope and AIM Biotech’s human BBB co-culture model to quantify permeability and identify structures of the 3D microenvironment: https://bit.ly/3UeHiFF

We often talk about how the 3D co-culture nature of assays better mimics the tumor microenvironment (TME). Here, we ha...
28/03/2023

We often talk about how the 3D co-culture nature of assays better mimics the tumor microenvironment (TME). Here, we have an example of a group using melanoma spheroids in a cancer-on-a-chip model based on AIM Biotech's idenTx platform in a way that highlights the value of a more realistic TME for investigating new therapies.

The authors demonstrate that the presence of stromal fibroblasts in the model is sufficient to inhibit the infiltration and tumor killing effects of NK-92 cells as an adoptive cell therapy approach. See their study here: https://www.mdpi.com/2306-5354/10/1/52

Interested in learning how idenTx can help you investigate cancer therapies with a physiologically relevant TME? Send us a message and let us know!



Check out this publication in Nature Communications from the Pavesi Lab, which includes a 3D cytotoxicity assay based on...
09/02/2023

Check out this publication in Nature Communications from the Pavesi Lab, which includes a 3D cytotoxicity assay based on AIM Biotech's idenTx platform. The team's results suggest a suggest a way to boost the efficacy of TCR or CAR-based cancer treatments, potentially reducing the need for multiple rounds of treatment. See all the details here: https://www.nature.com/articles/s41467-023-36160-5

For in-vitro of -killing treatments, functional vasculature is key to understanding real-world efficacy. See how ca...
10/01/2023

For in-vitro of -killing treatments, functional vasculature is key to understanding real-world efficacy. See how cancer-killing immune cells can't permeate the non-vascularized tumoroid on the left, but can attack the core of the vascularized tumoroid on the right. AIM Biotech's organiX platform enables a straightforward and reliable way to create tumor models with functional, perfusable vasculature, as shown in the center. Want to know more? Visit us at aimbiotech.com.

12/12/2022

In case you missed it, check out our recent webinar with our friends at Opentrons Labworks Inc. AIM Biotech’s Sei Hien Lim talks about how to scale up drug discovery research using AIM’s organiX and idenTx 3D tissue culture platforms in conjunction with the Opentrons OT-2 lab robot. For any questions this webinar may spark, reach out to us so we can help!

In case you missed it, check out our recent webinar with our friends at Opentrons Labworks Inc. AIM Biotech’s Sei Hien L...
12/12/2022

In case you missed it, check out our recent webinar with our friends at Opentrons Labworks Inc. AIM Biotech’s Sei Hien Lim talks about how to scale up drug discovery research using AIM’s organiX and idenTx 3D tissue culture platforms in conjunction with the Opentrons OT-2 lab robot. Reach out to us with any questions about the presentation so we can help!

https://vimeo.com/771191080

Your work with organoids and tissue biopsies is critical to your . Leverage the power to add functional vasculature to ...
17/11/2022

Your work with organoids and tissue biopsies is critical to your . Leverage the power to add functional vasculature to these tissues with organiX by AIM Biotech. Ready for automation, live cell imaging, and multi-omics—organiX is a revolution in 3D tissue culture for larger samples. Learn more at aimbiotech.com.

Reminder! If you'd like to learn how an platform and human can bridge the gap between lab cultures and animal studie...
09/11/2022

Reminder! If you'd like to learn how an platform and human can bridge the gap between lab cultures and animal studies, be sure to tune in to this free ! You'll also see how you can automate your workflow to get more done in your and .

Two sessions are available on Monday, Nov. 14! Learn more and sign up here: https://insights.opentrons.com/lp/webinar-11-14-22-aim-biotech

Hosted by AIM Biotech's Dr. Sei Hien Lim in partnership with Opentrons Labworks.

Consider an immune-competent environment with functional vasculature for your immune- assays. What if that environmen...
07/11/2022

Consider an immune-competent environment with functional vasculature for your immune- assays. What if that environment supported human or patient biopsy tissue up to 2mm in diameter? The organiX platform from AIM Biotech can do just that. Learn more about how organiX can humanize your drug development and clinical decision making at aimbiotech.com.

Bridge the gap. Accelerate your research. See a on how organ chips and close the distance between traditional cell c...
26/10/2022

Bridge the gap. Accelerate your research. See a on how organ chips and close the distance between traditional cell cultures and animal studies, and how you can automate your research workflow to get more done.

Dr. Lim Sei Hien from AIM Biotech will host a webinar next month discussing how its organ-on-a-chip platform and the OT-2 lab robot by Opentrons Labworks can help scale up assays for and .

Two sessions are available! Learn more and sign up here:
https://insights.opentrons.com/lp/webinar-11-14-22-aim-biotech

Session 1: November 14, 2022, 09:00 ET (13:00 GMT)
Session 2: November 14, 2022, 21:00 ET (02:00 GMT)

20/10/2022

Functional vasculature inside a tissue culture. What does that mean for the relevance of your assays? Is culturing vascularized or tumor biopsies valuable for functional ? AIM Biotech thinks so. Learn how organiX can empower your study at aimbiotech.com.

Address

21 Biopolis Road, #01-24 Nucleos
Singapore
138567

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Website

Alerts

Be the first to know and let us send you an email when AIM Biotech posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to AIM Biotech:

Shortcuts

Share

Category